Lorvotuzumab mertansine (ADC)
Lorvotuzumab mertansine is an ADC consisting of an NCAM-directed antibody and DM1, a potent derivative of maytansine, used for the study of several solid tumors and hematological tumors.
Product Specifications
Product Name Alternative
MGN901, huN901-DM1
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS8802459-01 48 Well
Human SIGLEC2 (Sialic Acid Binding Ig Like Lectin 2) ELISA Kit
Ask
View Details 
MBS8802459-02 96 Well
Human SIGLEC2 (Sialic Acid Binding Ig Like Lectin 2) ELISA Kit
Ask
View Details 
MBS8802459-03 5x 96 Well
Human SIGLEC2 (Sialic Acid Binding Ig Like Lectin 2) ELISA Kit
Ask
View Details MBS8802459-04 10x 96 Well
Human SIGLEC2 (Sialic Acid Binding Ig Like Lectin 2) ELISA Kit
Ask
View Details GTR15325270 1 Vial
Lentiviral human FZR1 shRNA (UAS) - Lentiviral human FZR1 shRNA (UAS) plasmid
Ask
View Details